Annual health care costs and lost earnings in the United States from low-level but daily exposure to hazardous chemicals commonly found in plastic bottles, metal food cans, detergents, flame retardants, toys, cosmetics, and pesticides, exceeds $340 billion, according to a detailed economic analysis by researchers at NYU Langone Medical Center.
Throughout her distinguished career, cancer researcher Dafna Bar-Sagi, PhD, has made fundamental contributions to the understanding of the mechanisms that drive the disease. In recognition of her accomplishments, she has been named a recipient of the Outstanding Investigator Award, a highly prestigious honor presented by the National Cancer Institute (NCI).
Dr. Feza Remzi named Director of IBD Center at NYU Langone Medical Center.
A new survey of children’s and teenagers’ eating habits at fast-food restaurants suggests that consumption levels of sugary drinks are closely tied to their automatic inclusion in “combo meal” packages.
After her own experience surviving breast cancer, philanthropist Beatrice Welters wanted to “pay it forward” -- and help educate other women about breast cancer and the importance of early detection. And she is doing just that -- through a new program at NYU Langone -- the Beatrice W. Welters Breast Health Outreach and Navigation Program.
A family-centered pre-k intervention developed at NYU Langone has a positive, lasting impact on child mental health and academic performance.
The Perlmutter Cancer Center at NYU Langone Medical Center has named noted clinician-scientist Kwok-Kin Wong, MD, PhD, as its new Chief of Hematology and Medical Oncology.
A naturally occurring enzyme called hyaluronidase may be an effective alternative treatment for spasticity, or muscle stiffness, a disabling condition in people who have had a stroke or other brain injury. That is the finding of a study from NYU Langone Medical Center published in the July print issue of EBioMedicine.
A group of proteins best known for helping to activate all mammalian genes has been found to play a particularly commanding role in the natural development of specialized stem cells into healthy blood cells, a process known as hematopoiesis.
In doses equivalent to those used regularly in human children, antibiotics changed the mix of gut microbes in young mice to dramatically increase their risk for type 1 diabetes.
A new technology creates images resolved enough to enable consistent diagnoses across populations for the first time.
On top of offering sound advice, NYU Lutheran also provides pregnant women with important clinical information about their pregnancies — using the most advanced ultrasound technology to assess how their baby is developing inside the womb.
Brooklyn has always been home to Josef A. Shehebar, MD, FACS, FASCRS. When he was recruited recently by NYU Lutheran to expand and grow the Division of Colon and Rectal Surgery, Dr. Shehebar couldn't pass up the opportunity to work in the borough where his roots are firmly planted.
Among the first clinical upgrades at NYU Lutheran since joining the NYU Langone Health System has been the installation of the da Vinci surgical system, one of the most advanced technologies used in robot-assisted surgery.
Hassenfeld Children’s Hospital of New York at NYU Langone experts present novel approaches to family-centered care at international conference.
Two new grants from the New York State Department of Health (NYSDOH) will enable New Yorkers with Alzheimer’s disease and dementia, and their families, to get the most comprehensive care and support services available in the New York City area. NYU Langone Medical Center is launching its Alzheimer’s and Related Dementias Family Support Program and is establishing a Center of Excellence for Alzheimer’s Disease.
NYU Langone and Winthrop-University Hospital today announced they have signed a non-binding letter of intent to begin discussions concerning a potential transaction that would bring the two organizations together to create an integrated healthcare network for the New York metropolitan region.
NYU Lutheran is determined to help stop prostate cancer in its tracks. And leading NYU Lutheran’s fight is Marc Bjurlin, DO, the hospital’s newly appointed director of urologic oncology and clinical assistant professor of urology at NYU School of Medicine.
Two of the highest-qualified neurosurgeons in New York City are now part of NYU Lutheran Medical Center, a member of NYU Langone Health System and its central hub in Brooklyn, and add decades of experience to one of the region’s most talented neurosurgery teams.
Renowned diabetes expert Mary Pat Gallagher, MD, named director of NYU Langone’s new comprehensive pediatric diabetes center.
The Cardiothoracic Surgery Department’s Heart Valve Center at NYU Langone Medical Center last week became the first center in the world to implant a new heart valve for transcatheter aortic valve replacement (TAVR) in a patient with severe aortic stenosis. As a principal center in the new clinical trial for the Medtronic CoreValve™ Evolut™ PRO TAVR System, NYU Langone is leading the advancement of new technology to help patients suffering from aortic stenosis who are at high to extremely high surgical mortality risk. The technology is only available for investigational use in the United States.
High saturated fats in breast tissue may be an indicator of cancer in postmenopausal women, study shows.
NYU Langone researchers publish first study to quantify nutritional quality of food and drinks endorsed by music celebrities popular among teens.
A new drug that harnesses the immune system to attack tumors is highly effective against advanced bladder cancer, according to the results of an international clinical trial to be presented June 5 at the annual meeting of the American Society for Clinical Oncology (ASCO).
Patients who don’t respond to treatments that use their own immune cells to destroy tumors, called tumor infiltrating lymphocytes, share changes in mechanisms that switch genes on or off in those cells, according to study results presented at the annual meeting of the American Society for Clinical Oncology (ASCO) on June 4 in Chicago.
The relentless desire by mice to run on cage “exercise” wheels has helped explain at a molecular level how exercise benefits a mammal’s brain.
Renowned psychiatrist and researcher Helen L. Egger, MD, has been appointed chair of NYU Langone’s Department of Child and Adolescent Psychiatry.
Men with low levels of the male sex hormone testosterone need not fear that testosterone replacement therapy will increase their risk of prostate cancer.
A pair of molecular signals controls skin and hair color in mice and humans — and could be targeted by new drugs to treat skin pigment disorders like vitiligo, according to a report by scientists at NYU Langone Medical Center.
Up to 20 percent of patients with high risk of relapse of acute lymphoblastic leukemia (ALL) are not cured. That could change with the results from a clinical trial co-led by NYU Langone Medical Center which shows giving high doses of a commonly-used chemotherapy drug increases survival rates.
The most aggressive form of pancreatic cancer – often described as one of the hardest malignancies to diagnose and treat -- thrives in the presence of neighboring tumor cells undergoing a particular form of “orchestrated cell death.” This according to a study recently published in Nature.
Drug-carrying “nanoghosts” that battle melanoma and new treatments for malignant mesothelioma will be the focus of the first joint research projects led by NYU Langone Medical Center and the Technion-Israel Institute of Technology under a groundbreaking research initiative.
The presence of certain bacteria in the mouth may reveal increased risk for pancreatic cancer and enable earlier, more precise treatment. This is the main finding of a study led by researchers at NYU Langone Medical Center and its Laura and Isaac Perlmutter Cancer Center to be presented April 19 in New Orleans at the annual meeting of the American Association for Cancer Research.
Infection with worms counters inflammatory bowel diseases (IBD) by triggering immune responses that change the mix of bacteria, or microbiome, in the gut. This is according to a study published online April 14 in the journal Science.
The American Association for Cancer Research (AACR) has announced that Dafna Bar-Sagi, PhD, senior vice president and vice dean for science and chief scientific officer at NYU Langone Medical Center, has been named to its Board of Directors for a three-year term.
The majority of people with post-traumatic stress disorder (PTSD) recover after early treatment -- but a substantial number still suffer for years after a traumatic event even with early clinical interventions, according to a study publishing online April 12 in The Journal of Clinical Psychiatry.
Nationally renowned schizophrenia expert W. Gordon Frankle, MD, MBA, has been named chief of the Psychiatric Service at NYU Lutheran Medical Center, a member of NYU Langone Health System and its central hub in Brooklyn.
Judith Hochman, MD, was awarded the ACC’s Distinguished Scientist Award in the Clinical Domain in honor of her contributions to the cardiovascular profession, and Sripal Bangalore, MD, was awarded the Douglas P. Zipes Distinguished Young Scientist Award in honor of his contributions to cardiovascular research. The awards were presented at the ACC’s Annual Scientific Sessions on April 4, 2016 in Chicago.
New findings from large-scale studies of more than 3.6 million people who underwent screening for cardiovascular disease reveals that a person’s age and gender affects the prevalence of certain types of peripheral vascular diseases (PVD), and that diabetes is a major risk factor for developing these diseases, even in patients without heart disease.
A clinical trial from NYU Langone Medical Center and others finds use of long-term, extended-release naltrexone leads to decreases in opioid addiction relapse. Learn more.
Renewing a commitment to advance its reputation in lung cancer and other thoracic malignancies, NYU Langone Medical Center has announced the appointment of physician-scientist Leena Gandhi, MD, PhD, as director of thoracic medical oncology at its Laura and Isaac Perlmutter Cancer.
Back pain is one of the most common medical complaints, affecting 8 out of 10 individuals at some point in their lives, according to the National Institutes of Health. Although most back pain subsides on its own, persistent problems can be signs of a more serious medical condition and can create a cascade of issues that greatly impact health and quality of life.
Smoking drastically alters the oral microbiome, the mix of roughly 600 bacterial species that live in people’s mouths. This is the finding of a study led by NYU Langone Medical Center and its Laura and Isaac Perlmutter Cancer Center to be published online March 25 in the ISME (International Society for Microbial Ecology) Journal.
Building on its national reputation in both cardiac research and women’s health, NYU Langone Medical Center has received nearly $4 million in a four-year research grant from the American Heart Association (AHA) and has been selected as a center in the AHA’s new Go Red For Women Research Network.
NYU Langone recognized for lesbian, gay, bisexual, and transgender (LGBT) healthcare equality by the Human Rights Campaign Foundation.
Evidence is mounting that a gene called PTCHD1 helps the brain sort between important sights and sounds — and distractions.
The bad intentions that often precede violence originate in a specific brain region, according to a study in mice led by researchers from NYU Langone Medical Center and published in Nature Neuroscience online March 7.
Implementing bundled payments for total joint replacements resulted in year-over-year improvements in quality of care and patient outcomes while reducing overall costs, according to a new three-year study from NYU Langone Medical Center. Specifically, NYU Langone’s Department of Orthopaedic Surgery saw reductions in overall length of stay, decreases in admission to follow-up care facilities and lower readmission rates at 30, 60, and 90 day intervals over the three-year study period.
Researchers at NYU Langone Medical Center are reporting they successfully performed CT scans for joint fractures with one-fourteenth the amount of normal radiation without compromising image quality or a surgeon’s ability to effectively diagnose an injury. Study could have significant implications from a public health and safety standpoint for patients with orthopaedic trauma who require CT scans.
A new cooling technique can both protect the brain’s speech centers during surgery and pinpoint the areas separately responsible for word formation and speech timing.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right